Inventor · disambiguated record
Kenneth Evan Thompson
Also filed as: THOMPSON KENNETH · THOMPSON KENNETH E · THOMPSON KENNETH EVAN
11 granted patents·7 pending applications·108 citations·filing 1980–2025
87Inventor score
Files withABCURO INC5APOGEE THERAPEUTICS INC2BRIGHAM & WOMENS HOSPITAL INC2LIFE TECHNOLOGIES CORP2THE BRIGHAM AND WOMENS HOSPITAL2
Top patents by PatentIndex Score
18 records- 0184US11339222B2KLRG1 antagonist signaling therapyTHE BRIGHAM AND WOMENS HOSPITAL·Filed 2017·Granted May 24, 2022·2 cites·41 claims
- 0284US4302922APruning boomORANGE ENTERPRISES INC·Filed 1980·Granted Dec 1, 1981·58 cites·8 claims
- 0379US6837145B1Fluid powered actuatorAIR POWER SYSTEMS CO INC·Filed 2002·Granted Jan 4, 2005·26 cites·14 claims
- 0478US11180561B2Killer cell lectin-like receptor subfamily G member 1 (KLRG1) depleting antibodiesABCURO INC·Filed 2020·Granted Nov 23, 2021·1 cites·23 claims
- 0576US2025101114A1Methods of treating disorders associated with excess or unwanted killer cell lectin-like receptor subfamily g member 1 (klrg1) expressing t cells with klrg1 depleting antibodiesABCURO INC·Filed 2024·Application pending·0 cites
- 0674US12358979B2Antibodies that bind interleukin 13 and methods of useAPOGEE THERAPEUTICS INC·Filed 2024·Granted Jul 15, 2025·0 cites·21 claims
- 0767US12139541B2Methods of treating disorders associated with excess or unwanted killer cell lectin-like receptor subfamily g member 1 (KLRG1) expressing t cells with KLRG1 depleting antibodiesABCURO INC·Filed 2021·Granted Nov 12, 2024·0 cites·19 claims
- 0867US2025297283A1Chemically-defined baculovirus expression systemLIFE TECHNOLOGIES CORP·Filed 2025·Application pending·0 cites
- 0965US8297586B1Proportional control pneumatic cylinderTHOMPSON KENNETH E·Filed 2006·Granted Oct 30, 2012·6 cites·20 claims
- 1060US12378575B2Chemically-defined baculovirus expression systemLIFE TECHNOLOGIES CORP·Filed 2019·Granted Aug 5, 2025·0 cites·18 claims
- 1160US2025368733A1Antibodies that bind interleukin 13 and methods of useAPOGEE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1259US2019085083A1Klrg1 signaling therapyTHE BRIGHAM AND WOMENS HOSPITAL·Filed 2018·Application pending·0 cites
- 1355US2025101112A1Killer cell lectin-like receptor subfamily g member 1 (klrg1) depleting antibodiesABCURO INC·Filed 2022·Application pending·0 cites
- 1454US2024174754A1Anti-klrg1 antibodiesABCURO INC·Filed 2022·Application pending·0 cites
- 1551US12365735B2Anti-KLRG1 antibodiesBRIGHAM & WOMENS HOSPITAL INC·Filed 2019·Granted Jul 22, 2025·0 cites·16 claims
- 1646US11015621B2Proportional control fluid actuatorAIR POWER SYSTEMS CO LLC·Filed 2019·Granted May 25, 2021·0 cites·20 claims
- 1742US5626090APlanting hole burning apparatusFiled 1996·Granted May 6, 1997·15 cites·15 claims
- 1841US2019194333A1Klrg1 depletion therapyBRIGHAM & WOMENS HOSPITAL INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kenneth Evan Thompson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →